Background B-cell maturation antigen (BCMA)–directed chimeric antigen receptor (CAR) T-cell
therapies have generated responses in patients with advanced myeloma, but relapses …

PURPOSE Photon involved-field radiotherapy (IFRT) is the standard-of-care radiotherapy for
patients with leptomeningeal metastasis (LM) from solid tumors. We tested whether proton …

SARS-CoV-2 infection induces a wide spectrum of neurologic dysfunction that emerges weeks
after the acute respiratory infection. To better understand this pathology, we prospectively …

Glioblastoma evades conventional therapies through a variety of mechanisms, including
suppression of the immune system. This immunosuppressive microenvironment provides a …

Leptomeningeal metastases arise from cancer cell entry into the subarachnoid space, inflicting
significant neurologic morbidity and mortality across a wide range of malignancies. The …

Purpose The efficacy of salvage resection (SR) of recurrent brain metastases (rBrM) following
stereotactic radiosurgery (SRS) is undefined. We sought to describe local recurrence (LR) …

The incidence of brain metastases continues to present a management issue despite the
advent of improved systemic control and overall survival. While the management of …

Leptomeningeal metastases represent an aggressive stage of cancer with few durable
treatment options. Improved understanding of cancer biology, neoplastic reliance on oncogenic …

Purpose of Review Liquid biopsy is a sampling of tumor cells or tumor nucleotides from
biofluids. This review explores the roles of liquid biopsy for evaluation and management of …

Purpose of Review Headaches are a common, oftentimes debilitating symptom in patients
with leptomeningeal metastases. Recent Findings The third edition of the International …